Johnson & Johnson raises 2026 guidance: what dividend investors should know
Johnson & Johnson raised its full-year 2026 guidance after posting stronger-than-expected results in its medical device segment. The healthcare conglomerate now expects faster earnings growth than it projected three months ago, sending a signal that […]
Johnson & Johnson raises 2026 guidance: what dividend investors should know Read More »
